New technology is allowing teams to analyze data at faster rates and make decisions much sooner than they previously could.
Ken McLaren
Advertisement
Articles by Ken McLaren
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Rebuilding Clinical Data Workflows for the AI Era
2
Roundup: Astellas Licenses IL-12 Fusion Protein From Audax in Deal Worth Up to $1.34 Billion, EVERSANA Acquires Health Economics Firm Estima Scientific
3
The Next Biopharma Revolution: Quantum Computing
4
Bristol Myers Squibb Discloses Patient Death in CAR-T Multiple Sclerosis Trial
5